研究疾病:
|
轻度认知功能损害
|
研究疾病代码:
|
|
Target disease:
|
Mild cognitive ment
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
随机平行对照
randomized controlled trial(parallel group design)
|
研究所处阶段:
Study phase:
|
I期临床试验
Phase I clinical trial
|
研究目的:
|
评估补肾健脾化痰方治疗aMCI的有效性及安全性。
|
Objectives of Study:
|
To evaluate the efficacy and safety of tonifying kidney and Invigorating Spleen and huatan decoction in the treatment of aMCI.
|
药物成份或治疗方案详述:
|
试验药物组成:石菖蒲,山萸肉,益智仁,生姜,葛根,黄精。
每次9克,每日2次,于早晚饭后0.5-1小时温水送服。
|
Description for medicine or protocol of treatment in detail:
|
Composition of the test drug: Acorus tatarinois, cornus meat, nooyi kernel, ginger, pueraria root, yellow essence.
9 grams each time, twice a day, in the morning and evening after meals 0.5-1 hours warm water to take.
|
纳入标准:
|
(1)符合本研究轻度认知损害的诊断标准;
(2)主诉记忆力减退,并得到周边人证实;
(3)年龄在45-85岁之间;
(4)简易精神状态检查量表(MMSE)在24-30分之间;
(5)与年龄不相符的客观记忆力下降,逻辑故事回忆延迟回忆得分比年龄或教育匹配人群小1.5标准差(SD)到2SD;
(6)日常生活能力基本正常,其严重程度达不到痴呆诊断标准;
(7)海金斯基缺血量表(HIS)评分在7分及以下;
(8)汉密尔顿抑郁量表(HAMD)评分在12分及以下;
(9)中医证候诊断标准即PES-11中肾虚、脾虚、痰浊三项证候至少有一项≥7分;
(10)有一定文化程度,能阅读简单的文章、书写简单的句子;
(11)有足够的听力和视力配合测评;
(12)受试者和照料者愿意签署知情同意书。
|
Inclusion criteria
|
(1) Meet the diagnostic criteria of mild cognitive impairment in this study;
(2) The chief complaint was memory loss, which was confirmed by the surrounding people;
(3) Aged between 45 and 85;
(4) The MMSE ranged from 24 to 30 points;
(5) age-inconsistent objective memory decreased, and delayed recall score of logical story recall was 1.5 SD (SD) to 2SD (SD) smaller than that of age or education matched group.
(6) The ability of daily living is basically normal, and the severity of dementia is not up to the diagnostic criteria;
(7) Heginsky ischemia Scale (HIS) score was 7 or less;
(8) Hamilton Depression Scale (HAMD) score of 12 or below;
(9) The standard of TCM syndrome diagnosis is pES-11, namely, at least one of the three syndromes of kidney eficiency, spleen deficiency and phlegm turbidity ≥7 points;
(10) Have a certain degree of education, can read simple articles, write simple sentences;
(11) Adequate hearing and vision assessment;
(12) Subjects and caregivers are willing to sign informed consent.
|
排除标准:
|
(1)存在任何引起痴呆的神经系统疾病,如帕金森、多系统萎缩、进行性核上性麻痹、亨廷顿病、血管性痴呆、正常压力脑积水、脑肿瘤、癫痫、脑出血后脑水肿吸收前或蛛网膜下腔出血急性期、慢性硬膜下血肿及多发性硬化,有严重头脑外伤史伴有持续神经功能缺损或已知的脑结构异常;
(2)存在临床上尚未控制的心、脑血管疾病、肝肾代谢异常疾病、消化性溃疡活动期;
(3) 抑郁状态(HAMD>7分),或其他精神障碍;
(4)存在甲状腺功能异常、显著的Vb12或叶酸缺乏;
(5)神经心理学测评前 72 小时内服用过抗精神病药;
(6)神经心理学测评前 48 小时内服用过拟交感药、抗组胺药、抗焦虑药、安定;
(7)嗜酒、酒精滥用史;
(8)有严重的神经功能缺损以至于不能完成相关检查者,如便利手偏瘫、各种失语、视听障碍等。
|
Exclusion criteria:
|
(1) The presence of any neurological disease causing dementia, such as Parkinson's disease, multisystem atrophy, progressive supranuclear palsy, Huntington's disease, vascular dementia, normal pressure hydrocephalus, brain tumors, epilepsy, cerebral edema after cerebral hemorrhage before absorption or subarachnoid hemorrhage in the acute phase, chronic subdural hematoma and multiple sclerosis, A history of severe head trauma with persistent neurological deficits or known brain structural abnormalities;
(2) The presence of clinically uncontrolled cardiovascular and cerebrovascular diseases, abnormal liver and kidney metabolism diseases, peptic ulcer active stage;
(3) Depressive state (HAMD>7), or other mental disorders;
(4) thyroid dysfunction, significant Vb12 or folic acid deficiency;
(5) had taken antipsychotic drugs within 72 hours before the neuropsychological assessment;
(6) Had taken sympathomimetic drugs, antihistamines, antianxiety drugs and diazepam within 48 hours before the neuropsychological assessment;
(7) History of alcohol addiction and abuse;
(8) Those who have serious neurological defects and cannot complete relevant examinations, such as convenient hand hemiplegia, various aphasia, audio-visual impairment, etc.
|
研究实施时间:
Study execute time:
|
从From
2020-06-01
至To
2023-06-01
|
征募观察对象时间:
Recruiting time:
|
从From
2021-12-15
至To
2023-06-01
|